Skip to main content
logo
Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
6.15
-0.12 (-1.91%)
At close: Mar 19, 2026

SHA:688373 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-440.72-421.12-220.3-226.27
Depreciation & Amortization
14.1714.1215.312.11
Other Amortization
3.493.712.171.6
Loss (Gain) From Sale of Assets
-0.03-0-0.490.02
Loss (Gain) From Sale of Investments
-17.08-33.34-18.49-10.53
Stock-Based Compensation
37.5337.1428.2245.39
Provision & Write-off of Bad Debts
0.770.330.20.03
Other Operating Activities
12.889.187.065.13
Change in Accounts Receivable
-24.4111.47-58.49-14.76
Change in Inventory
-15.42-15.63-10.88-5.58
Change in Accounts Payable
-18.8766.9228.7111.28
Change in Unearned Revenue
0.5-1.85-130.6
Operating Cash Flow
-447.18-329.08-240.01-180.98
Capital Expenditures
-0.91-7.66-12.18-22.91
Sale of Property, Plant & Equipment
0.03-1.5-
Investment in Securities
495.51305.24-737.635
Other Investing Activities
20.1737.0514.8610.11
Investing Cash Flow
514.8334.63-733.4222.2
Long-Term Debt Issued
10560148.7553.25
Long-Term Debt Repaid
-32.34-75.01-84.35-19.33
Net Debt Issued (Repaid)
72.66-15.0164.433.92
Issuance of Common Stock
1.98-981.775.09
Common Dividends Paid
--4.6-3.3-0.7
Other Financing Activities
-6.54--14.72-10.63
Financing Cash Flow
68.09-19.611,02827.68
Foreign Exchange Rate Adjustments
0.140.451.16-0.2
Net Cash Flow
135.86-13.6155.88-131.3
Free Cash Flow
-448.1-336.74-252.18-203.89
Free Cash Flow Margin
-343.97%-370.96%-523.13%-2661.81%
Free Cash Flow Per Share
-0.68-0.51-0.43-0.39
Cash Interest Paid
6.54---
Cash Income Tax Paid
27-9.87-7.20.39
Levered Free Cash Flow
-286.51-172.29-178.87-141.67
Unlevered Free Cash Flow
-279.54-165.95-173.36-138.4
Change in Working Capital
-58.260.9-53.67-8.47
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.